Slow, tight binding inhibition

Slow, tight-binding inhibition occurs when slow-binding inhibition takes place at inhibitor concentrations comparable to that of the enzyme, in which case the previous two mechanisms can still apply. Comprehensive review articles on the subject of tight, slow, and slow, tight-binding inhibitors ate available in the literature (12,14). 

Morrison JR 1982. The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions. Trends Biochem... 

This article describes various approaches to inhibition of enzyme catalysis. Reversible inhibition includes competitive, uncompetitive, mixed inhibition, noncompetitive inhibition, transition state, and slow tight-binding inhibition. Irreversible inhibition approaches include affinity labeling and mechanism-based enzyme inhibition. The kinetics of the various inhibition approaches are summarized, and examples of each type of Inhibition are presented. 

Kinetics of Siow-Binding Inhibition and Slow Tight-Binding inhibition... 

Scheme 5 Slow-binding or slow tight-binding inhibition.

In addition to its broad-spectrum biocidal activity, triclosan (22) displays reversible inhibition of E. coli Fabl with a picomolar K, for binding the enzyme-cofactor complex [4]. Triclosan entry results in the reordering of a loop of amino acids close to the active site, making it a slow, tight-binding inhibitor [41]. 

A (rapidly) reversible inhibitor will permit rapid and complete recovery of enzyme activity by dialysis. However, irreversible inhibitors are not removed by this procedure. Recovery from tight-binding inhibition is usually slow it is not uncommon for several dialysis bags containing enzyme to be prepared and for activity in each to be determined at various time points following the commencement of dialysis. The off-rate of these inhibitors is generally more rapid at higher temperatures. 

Some inhibitors interact very slowly with the enzyme protein, and onset of inhibition thus exhibits time-dependence. These inhibitors are generally referred to as slow-binding inhibitors, and as slow tight-binding inhihitors if the potency of inhibition is extremely high. Analysis of these inhibitory mechanisms is complex because binding and dissociation rate constants may be determined in addition to values. Indeed, a complete analysis may require extensive use of specialized computer software, and the complexities of such analyses preclude their discussion in this chapter. However, the reader is directed to several publications from Morrison s laboratory if a slow-binding mechanism is suspected for an inhibitor of interest (Morrison, 1982 Morrison and Stone, 1985 Sculley and Morrison, 1986 Morrison and Walsh, 1988). 

All three assumptions can be violated in the case of CYP enzymes, depending on the design of the in vitro CYP inhibition study. The first assumption can be potentially violated if the drug being tested is a time-dependent inhibitor (e.g., one with a slow on rate see below). The potency of some inhibitors (e.g., the CYP3A inhibitors ketoconazole and clotrimazole) is such that the free concentration of the inhibitor tends to approach the concentration of the enzyme (40), a violation of the second assumption. In the case of such tight-binding inhibition, an apparent A) value (A i a ) )) can be estimated, as follows ... 

Sulindac sulfide, the bioactive metabolite of sulindac, is struchirally very similar to INDO and is a slow, tight-binding inhibitor of COX (Fig. 2b) (12, 13). As with INDO, removal of the methyl group from sulindac sulfide results in loss of COX-1 and COX-2 inhibition (14). However, it should be noted that the benzylidine double bond of rfei-methyl sulindac sulfide (DM-SS) exists in the F-conformation, whereas sulindac sulfide exists in the Z-conformer. 

---